Purchase one-time access:Academic and Personal
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.British journal of haematology. 2004; 124: 106-113
- Red blood cell membrane disorders.British journal of haematology. 1999; 104: 2-13
- Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.American journal of clinical pathology. 2014; 142: 474-484
- Flow Cytometric Eosin-5'-Maleimide Test is a Sensitive Screen for Hereditary Spherocytosis.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion. 2018; 34: 491-494
- Usefulness of the eosin-5'-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis.British journal of haematology. 2008; 140: 468-470
- Flow cytometry test for hereditary spherocytosis.Haematologica. 2012; 97 (author reply e50-1): e47
- Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics.Haematologica. 2012; 97: 516-523
- Density, heterogeneity and deformability of red cells as markers of clinical severity in hereditary spherocytosis.Haematologica. 2020; 105: 338-347
- The Complexity of Genotype-Phenotype Correlations in Hereditary Spherocytosis: A Cohort of 95 Patients: Genotype-Phenotype Correlation in Hereditary Spherocytosis.HemaSphere. 2019; 3: e276
- Hereditary red cell membrane disorders and laboratory diagnostic testing.International journal of laboratory hematology. 2013; 35: 237-243
- Blood cell parameters for screening and diagnosis of hereditary spherocytosis.Journal of clinical laboratory analysis. 2019; 33e22844
Publication stageIn Press Accepted Manuscript
The authors declare no conflicts of interest.